FDA Archives - chatsaudicam.com

Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person

11/25/2020 an, announces, approval, contact, FDA, following, for, Genentech, infected, influenza:, of, Person, Prevention, the, with, Xofluza

South San Francisco, CA — November 23, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:

Health News

Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

11/24/2020 (lacosamide), and, approved, by, Epilepsy, Expanded, FDA, for, Generalized, living, now, Pediatric, People, Primary, seizures, Tonic-Clonic, Use, Vimpat, with

ATLANTA, Nov. 17, 2020 /PRNewswire/ — UCB, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration

Health News

FDA allows 1st rapid virus test that gives results at home

11/18/2020 1st, allows, at, FDA, Gives, home, rapid, results, test, that, virus

U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed entirely at home

Health News

FDA approves first COVID-19 drug. But it’s ‘not a blockbuster.’

10/23/2020 A, Approves, blockbuster.', but, COVID-19, drug, FDA, first, its, not

The U.S. Food and Drug Administration (FDA) has fully approved remdesivir as a treatment for COVID-19. The drug is now

Health News

Novel bioresorbable, tissue-healing surgical device approved by FDA

10/21/2020 approved, bioresorbable, by, device, FDA, Novel, surgical, tissue-healing

A new surgical tendon fixation system that not only re-attaches damaged tissues but also facilitates healing as it is absorbed

Health News

RedHill Biopharma Announces FDA Orphan Drug Designation for RHB-204 for the Treatment of NTM Infections

10/21/2020 announces, Biopharma, Designation, drug, FDA, for, infections, NTM, of, Orphan, RedHill, RHB-204, the, treatment

TEL AVIV, Israel and RALEIGH, NC, October 14, 2020, RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today

Health News

FDA warns companies about illegal sales of dietary supplements

10/15/2020 About, Companies, dietary, FDA, illegal, of, sales, supplements, warns

(HealthDay)—Warning letters have been sent to five companies for illegally selling dietary supplements that contain cesium chloride, the U.S. Food

Health News

New osteosarcoma treatment receives rare pediatric disease designation from the FDA

10/02/2020 Designation, disease, FDA, from, new, osteosarcoma, Pediatric, rare, Receives, the, treatment

Innova Therapeutics Inc., a biotechnology company dedicated to developing innovative cancer therapies for patients who have inadequate treatment options, recently

Health News

Khondrion Receives Rare Pediatric Disease Designation for Sonlicromanol from US FDA

09/29/2020 Designation, disease, FDA, for, from, Khondrion, Pediatric, rare, Receives, Sonlicromanol, US

September 28, 2020 — Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease, today announces that it

Health News

FDA Approves Nucala (mepolizumab) as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

09/27/2020 (HES), (mepolizumab), and, Approves, As, Biologic, FDA, first, for, Hypereosinophilic, Nucala, only, syndrome, the, treatment

London UK 25 September 2020 — GlaxoSmithKline plc (GSK) today announced the US Food and Drug Administration (FDA) has approved

← Previous